Hyperion Therapeutics
Latest round
- Series D
Last raised
- Oct 2011
Total raised
- $105M
Investors
- 6
About Hyperion Therapeutics
Hyperion Therapeutics is a biotechnology company focused on developing innovative therapies for patients suffering from rare diseases and metabolic disorders.Hyperion Therapeutics, founded in 2006, is headquartered in San Francisco, US. The company specializes in the development of treatments for rare diseases and metabolic disorders. The company has completed a total of 8 deals, with the most recent deal occurring on July 26, 2012.Hyperion Therapeutics develops specialized therapies aimed at addressing unmet medical needs in rare diseases and metabolic disorders.Hyperion Therapeutics plans to use the proceeds from its recent IPO to accelerate research and development of new therapeutic products specifically targeting rare diseases. The company is also exploring opportunities to expand its market presence into Europe and Asia-Pacific regions by 2024, aiming to reach more patients in need of its innovative treatments.
Who invested in Hyperion Therapeutics
6 investors across 4 rounds
See all investors in Hyperion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hyperion Therapeutics
Who invested in Hyperion Therapeutics?
Hyperion Therapeutics has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hyperion Therapeutics raised?
Hyperion Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Hyperion Therapeutics last raise money?
Hyperion Therapeutics's most recent round on record is a Series D, in Oct 2011.
What does Hyperion Therapeutics do?
Hyperion Therapeutics is a biotechnology company focused on developing innovative therapies for patients suffering from rare diseases and metabolic disorders.
Where is Hyperion Therapeutics headquartered?
Hyperion Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Hyperion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Hyperion Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Hyperion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.